| | | | |
| Please limit public testimony to 3 minutes. The public is also welcome to |
|
| submit copies of written testimony to the Committee. |
|
|
| | | | |
| | Relating to reimbursement under the state Medicaid program for certain health care services provided through telemedicine. |
|
|
|
|
| | | | |
| | Relating to background and criminal history checks for certain providers of subsidized child care. |
|
|
|
|
| | | | |
| | Relating to civil remedies and qui tam provisions under the Medicaid fraud prevention act. |
|
|
|
|
| | | | |
| | Relating to restrictions on the substitution of generically equivalent versions of antiepileptic and antiseizure drugs. |
|
|
|
|
| | | | |
| | Relating to restrictions on the substitution of generically equivalent versions of transplant immunosuppresants. |
|
|
|
|
| | | | |
| | Relating to retaliation for reports of possible abuse, neglect, or exploitation of certain persons receiving home and community-based services. |
|
|
|
|
| | | | |
| | Relating to certain requirements relating to permanency hearings and placement review hearings for children under the care of the Department of Family and Protective Services. |
|
|
|
|
| | | | |
| | Relating to participation and reimbursement of telemedicine medical service providers under the Medicaid program. |
|
|
|
|
| | | | |
| | Relating to reports by nurses of certain conduct and protection from retaliation for those nurses. |
|
|
|
|
| | | | |
| | Relating to the certification of mammography systems. |
|
|
|
|